BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25407051)

  • 1. Levels of human replication factor C4, a clamp loader, correlate with tumor progression and predict the prognosis for colorectal cancer.
    Xiang J; Fang L; Luo Y; Yang Z; Liao Y; Cui J; Huang M; Yang Z; Huang Y; Fan X; Wang H; Wang L; Peng J; Wang J
    J Transl Med; 2014 Nov; 12():320. PubMed ID: 25407051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RFC4 promotes the progression and growth of Oral Tongue squamous cell carcinoma in vivo and vitro.
    Zhang J; Wang L; Xie X
    J Clin Lab Anal; 2021 May; 35(5):e23761. PubMed ID: 33783864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide RNAi Screening Identifies RFC4 as a Factor That Mediates Radioresistance in Colorectal Cancer by Facilitating Nonhomologous End Joining Repair.
    Wang XC; Yue X; Zhang RX; Liu TY; Pan ZZ; Yang MJ; Lu ZH; Wang ZY; Peng JH; Le LY; Wang GY; Peng QH; Meng Y; Huang W; Liu RY
    Clin Cancer Res; 2019 Jul; 25(14):4567-4579. PubMed ID: 30979744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MTSS1 overexpression correlates with poor prognosis in colorectal cancer.
    Wang D; Xu MR; Wang T; Li T; Zhu Jw
    J Gastrointest Surg; 2011 Jul; 15(7):1205-12. PubMed ID: 21562916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties and Clinical Relevance of Speckle-Type POZ Protein in Human Colorectal Cancer.
    Xu J; Wang F; Jiang H; Jiang Y; Chen J; Qin J
    J Gastrointest Surg; 2015 Aug; 19(8):1484-96. PubMed ID: 26022775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulated CNTN1 is associated with lymph node metastasis and poor prognosis of colorectal cancer.
    Li G; Zhang Z; Ge G; Fang K; Zhu J
    Cancer Biomark; 2021; 30(2):193-201. PubMed ID: 33104020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the phosphorylated MEK5 protein is associated with TNM staging of colorectal cancer.
    Hu B; Ren D; Su D; Lin H; Xian Z; Wan X; Zhang J; Fu X; Jiang L; Diao D; Fan X; Wang L; Wang J
    BMC Cancer; 2012 Mar; 12():127. PubMed ID: 22458985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replication Factor C4 in human hepatocellular carcinoma: A potent prognostic factor associated with cell proliferation.
    Chen P; Liu Y; Ma X; Li Q; Zhang Y; Xiong Q; Song T
    Biosci Trends; 2021 Sep; 15(4):249-256. PubMed ID: 34053971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The function of BTG3 in colorectal cancer cells and its possible signaling pathway.
    Lv C; Wang H; Tong Y; Yin H; Wang D; Yan Z; Liang Y; Wu D; Su Q
    J Cancer Res Clin Oncol; 2018 Feb; 144(2):295-308. PubMed ID: 29270670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p42.3: a promising biomarker for the progression and prognosis of human colorectal cancer.
    Yuan XS; Zhang Y; Guan XY; Dong B; Zhao M; Mao LL; Lu YY; Tian XY; Hao CY
    J Cancer Res Clin Oncol; 2013 Jul; 139(7):1211-20. PubMed ID: 23576022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression level and nuclear localization of Sam68 are associated with progression and poor prognosis in colorectal cancer.
    Liao WT; Liu JL; Wang ZG; Cui YM; Shi L; Li TT; Zhao XH; Chen XT; Ding YQ; Song LB
    BMC Gastroenterol; 2013 Aug; 13():126. PubMed ID: 23937454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of MUC20 overexpression as a predictor of recurrence and poor outcome in colorectal cancer.
    Xiao X; Wang L; Wei P; Chi Y; Li D; Wang Q; Ni S; Tan C; Sheng W; Sun M; Zhou X; Du X
    J Transl Med; 2013 Jun; 11():151. PubMed ID: 23787019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of fibronectin is associated with poor prognosis, cell proliferation and malignancy via the NF-κB/p53-apoptosis signaling pathway in colorectal cancer.
    Yi W; Xiao E; Ding R; Luo P; Yang Y
    Oncol Rep; 2016 Dec; 36(6):3145-3153. PubMed ID: 27748871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and clinical significance of absent in melanoma 2 in colorectal cancer.
    Zhang Z; Dong X; Yang X; Wan D; Sun L; Gu M; Li M; Zhu Z; Wang J; Shang Z; He S
    Biomed Pharmacother; 2017 Oct; 94():843-849. PubMed ID: 28802238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of UQCRC2 is correlated with tumor progression and poor prognosis in colorectal cancer.
    Shang Y; Zhang F; Li D; Li C; Li H; Jiang Y; Zhang D
    Pathol Res Pract; 2018 Oct; 214(10):1613-1620. PubMed ID: 30115536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of CASK correlates with progression and poor prognosis of colorectal cancer.
    Wei JL; Fu ZX; Fang M; Zhou QY; Zhao QN; Guo JB; Lu WD; Wang H
    Tumour Biol; 2014 Sep; 35(9):9185-94. PubMed ID: 24927672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
    Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
    Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of the PLAGL1 (ZAC1/LOT1) gene in colorectal cancer: Correlations to the clinicopathological parameters.
    Kowalczyk AE; Krazinski BE; Godlewski J; Kiewisz J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Kiezun J; Wierzbicki PM; Bodek G; Sulik M; Kmiec Z
    Int J Oncol; 2015 Sep; 47(3):951-62. PubMed ID: 26134521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer.
    Chu XY; Zhu ZM; Chen LB; Wang JH; Su QS; Yang JR; Lin Y; Xue LJ; Liu XB; Mo XB
    Acta Histochem; 2012 Dec; 114(8):755-62. PubMed ID: 22326401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UHRF1 promotes cell growth and metastasis through repression of p16(ink⁴a) in colorectal cancer.
    Wang F; Yang YZ; Shi CZ; Zhang P; Moyer MP; Zhang HZ; Zou Y; Qin HL
    Ann Surg Oncol; 2012 Aug; 19(8):2753-62. PubMed ID: 22219067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.